Clinical Trial Update: Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intracoronary injection of autologous bone marrow mononuclear cells for left ventricular contractility and remodeling after myocardial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Autologous bone marrow mononuclear cells (bone marrow mononuclear cells)

Snippet

Sponsor: American Heart of Poland | Conditions: Heart Failure, Myocardial Infarction | Phase 3 | Status: UNKNOWN